Alon Harris Explained

Alon Harris
Occupation:Clinical Scientist
Professor of Ophthalmology
Work Institutions:Icahn School of Medicine at Mount Sinai
Visiting ProfessorshipsLithuanian University of Health Sciences, Lithuania
Ben Gurion University Medical Center, Be’er Sheva, Israel
Tel Aviv University
Education:Indiana University
Research Field:Ophthalmology
Children:Jonathan and Danielle

Alon Harris is an American clinical scientist, professor of ophthalmology and Professor of Artificial Intelligence and Human Health,[1] educator, inventor and researcher in the field of ocular blood flow and its relationship to diseases of the eye. Harris served as the principal or co-principal investigator on more than 60 research grants, published more than 392 peer-reviewed articles, and wrote 23 books and 70 book chapters.[2] As of 2021, he holds two patents. Harris sits on the board of directors and the Scientific Advisory Board of The Glaucoma Foundation[3] and is the Vice Chair of International Research and Academic Affairs, co-director of the Center for Ophthalmic Artificial Intelligence and Human Health at Mount Sinai Hospital, and Director of the Ophthalmic Vascular Diagnostic and Research Program at Icahn School of Medicine at Mount Sinai.[4]

Career and education

Harris's post-doctorate training in medical science physiology was at Indiana University in 1990. He received an MS in 1985 and PhD in 1988 in human performance/physiology. Subsequently, he took positions at Indiana University School of Medicine, including the Lois Letzter Endowed Chair in Ophthalmology,[5] Professor of Ophthalmology, Professor of Cellular and Integrative Physiology, and Director, Glaucoma Research and Diagnostic Center, Department of Ophthalmology.[6] [7] He served as Director of Clinical Research at the Glick Eye Institute.[8] [9] Harris was co-chair, World Glaucoma Congress Consensus on Ocular Blood Flow,[10] and was a member of the international faculty board of the PhD program in Experimental Medicine, University of Pavia.

Research

Harris's clinical research focus includes: ocular blood flow;[11] glaucoma; intraocular pressure and hemodynamics related to eye disorders;[12] ophthalmic risk factor assessment; structural and functional progression monitoring; non-evasive imaging of diseases such as glaucoma; brain and eye physiology; modeling for factors that increase or decrease disease susceptibilities in terms of race, gender, and conditions such as diabetes.[13] [14] In collaboration with mathematicians, Harris uses modeling and artificial intelligence applications to increase precision of diagnostics and disease management.[15]

Grants

Harris has multiyear support from the National Science Foundation, grants from the NIH, American Diabetes Association and National Eye Institute. As of 2020, he has served as co-investigator or principal investigator (PI) on more than 60 grants related to ocular vascular physiology.[16] [17] [18] He was co-PI on The Thessaloniki Eye Study, reportedly ophthalmology's largest population-based study.

Patents

Harris is co-inventor on an international patent application, Methods and systems for patient specific identification and assessment of ocular disease risk factors and treatment efficacy,[19] He developed and generated data for two patents: "Treatment of Macular Edema"[20] and "Method to increase retinal and optical nerve head blood flow velocity in order to preserve sight."[21] [22]

Publications

Editorial boards

Harris is the founder and co-editor of Modeling and Artificial Intelligence in Ophthalmology (formerly Journal of Modeling in Ophthalmology).[23] [24] As of 2020, he is also on the board of the Journal of Ophthalmology,[25] Acta Ophthalmologica Scandinavica,[26] Journal of Glaucoma,[27] and PLOS ONE.[28]

Books and book chapters

Partial list:

Peer-reviewed papers

Google Scholar reports that Harris's publications are cited 18,871 times, that he has an h-index of 75 and an i10-index of 280.[29] Partial list of peer-reviewed papers:

Memberships and awards

Partial list of honors and awards:

As of 2020, memberships include:

See also

External links

Notes and References

  1. Web site: Alon Harris Icahn School of Medicine . 2023-06-11 . Icahn School of Medicine at Mount Sinai . en-US.
  2. Web site: Alon Harris, MS, PhD, FARVO – The Glaucoma Foundation. 2022-02-20. en-US. 2022-02-20. https://web.archive.org/web/20220220042456/https://glaucomafoundation.org/our_staff/alon-harris-ms-phd-farvo/. live.
  3. Web site: Board of Directors – The Glaucoma Foundation. 2022-02-19. en-US. 2022-02-19. https://web.archive.org/web/20220219233954/https://glaucomafoundation.org/about-tgf/board-of-directors/. live.
  4. Web site: Alon Harris Mount Sinai - New York. 2020-11-29. Mount Sinai Health System. en-US. 2021-09-03. https://web.archive.org/web/20210903203138/https://www.mountsinai.org/profiles/alon-harris. live.
  5. Web site: Elections: Member Listing: Alliance of Distinguished and Titled Professors. 2020-12-14. alliance.iu.edu. 2020-08-16. https://web.archive.org/web/20200816003409/https://alliance.iu.edu/members/member.html?id=2010. live.
  6. Web site: Alon Harris. 2020-11-28. PracticeUpdate. en. 2021-01-25. https://web.archive.org/web/20210125035701/https://www.practiceupdate.com/author/alon-harris/2185. live.
  7. Web site: Alon Harris, Professor of Ophthalmology, Eugene and Marilyn Glick Eye Institute. 2020-11-29. 10times.com. 2022-02-22. https://web.archive.org/web/20220222184358/https://10times.com/profile/alon-harris-15274547. live.
  8. Web site: 2011-04-14. Glick Eye Institute Sponsors Second Annual Vision Research Symposium. 2020-11-29. news. en. 2020-11-27. https://web.archive.org/web/20201127235431/https://medicine.iu.edu/news/2011/04/glick-eye-institute-sponsors-second-annual-vision-research-symposium. live.
  9. Web site: Does Diabetes Cause Glaucoma?. 2020-12-08. Diabetes Forecast. en. 2020-11-27. https://web.archive.org/web/20201127201558/http://www.diabetesforecast.org/2013/may/does-diabetes-cause-glaucoma.html. live.
  10. Web site: October 18, 2011. SCIENCEBASED HEALTH WELCOMES TWO NEW MEMBERS TO ITS SCIENTIFIC ADVISORY BOARD: JEFFREY BLUMBERG, PhD, FACN, FASN, CNS AND ALON HARRIS, MS, PhD, FARVO. live. https://web.archive.org/web/20130120054407/http://www.sciencebasedhealth.com/Assets/PDF/PressRelease/Jeffrey_Blumberg_%26_Alon_Harris_Join_SBH_Scientific_Advisory_Board.pdf. January 20, 2013. December 14, 2020. sciencebasedhealth.
  11. Shoshani. Yochai Z.. Harris. Alon. Siesky. Brent A.. 2010-04-01. Advances in the understanding of ocular blood flow in glaucoma. Expert Review of Ophthalmology. 5. 2. 189–200. 10.1586/eop.10.17. 71507020. 1746-9899.
  12. Web site: Alon Harris. 2020-11-28. Indiana University School of Medicine. en.
  13. Web site: The Association for Research in Vision and Ophthalmology-. 2020-11-29. www.arvo.org. 2021-04-12. https://web.archive.org/web/20210412231721/https://www.arvo.org/meetings/bench-to-bedside-meeting/speaker-information/. live.
  14. Harris. Alon. African and European Descent, Ocular Blood Flow and Glaucoma Progression. en. 2021-04-05. 2022-02-22. https://web.archive.org/web/20220222184352/https://grantome.com/grant/NIH/R21-EY022101-01A1. live.
  15. Guidoboni. Giovanna. Chong. Rachel Shujuan. Marazzi. Nicholas. Chee. Miao Li. Wellington. Jessica. Lichtenegger. Emily. Cheng. Ching-Yu. Harris. Alon. 2020-06-10. A mechanism-driven algorithm for Artificial Intelligence in ophthalmology: understanding glaucoma risk factors in the Singapore Eye Diseases Study. Investigative Ophthalmology & Visual Science. en. 61. 7. 619. 1552-5783. 2021-04-05. 2020-06-20. https://web.archive.org/web/20200620104503/http://iovs.arvojournals.org/article.aspx?articleid=2769957. live.
  16. Web site: Bio. Qlaris. Innovative ocular therapeutics. 2020-11-29. Qlaris Bio. en-US. 2020-11-27. https://web.archive.org/web/20201127002137/https://qlaris.bio/about-us. live.
  17. Web site: Grantome: Search. 2020-12-08. Grantome. en. 2020-12-08. https://web.archive.org/web/20201208051155/https://grantome.com/search. live.
  18. Web site: Drs. Giovanna Guidoboni and Alon Harris, Indiana University. 2020-12-08. EurekAlert!. en.
  19. Methods and systems for patient specific identification and assessment of ocular disease risk factors and treatment efficacy. 2016-12-01. Harris. Guidoboni. Alon. Giovanna. WO. 2016191277. Indiana University Research & Technology Corporation.
  20. US. 6046223. Treatment of macular edema. 2000-04-04. Sponsel. William Eric. Harris. Alon. Advanced Research & Technology Institute.
  21. Web site: Alon Harris, MS, PhD, FARVO – The Glaucoma Foundation. 2022-02-19. en-US. 2022-02-20. https://web.archive.org/web/20220220042456/https://glaucomafoundation.org/our_staff/alon-harris-ms-phd-farvo/. live.
  22. US. 5789435. Method to increase retinal and optical nerve head blood flow velocity in order to preserve sight. 1998-08-04. Harris. Alon. Sponsel. William Eric. Advanced Research & Technology Institute.
  23. Web site: Editorial Team Modeling and Artificial Intelligence in Ophthalmology. 2020-11-29. www.modeling-ophthalmology.com. 2020-10-24. https://web.archive.org/web/20201024234850/https://modeling-ophthalmology.com/index.php/JMO/about/editorialTeam. live.
  24. Web site: About the Journal Modeling and Artificial Intelligence in Ophthalmology. 2020-11-29. www.modeling-ophthalmology.com. 2020-11-28. https://web.archive.org/web/20201128223331/https://modeling-ophthalmology.com/index.php/JMO/about. live.
  25. Web site: Madridge Publishers. 2020-11-28. madridge.org. en-us. 2020-11-25. https://web.archive.org/web/20201125080809/https://madridge.org/. live.
  26. Web site: Acta Ophthalmologica. 2020-12-17. Wiley Online Library. 10.1111/(ISSN)1755-3768. en. 2021-08-23. https://web.archive.org/web/20210823134807/https://onlinelibrary.wiley.com/page/journal/17553768/homepage/EditorialBoard.html. live.
  27. Web site: Editorial Board : Journal of Glaucoma. 2020-12-17. journals.lww.com. en-US. 2020-09-24. https://web.archive.org/web/20200924222714/https://journals.lww.com/glaucomajournal/pages/editorialboard.aspx. live.
  28. Fang. I-Mo. Chen. Li-Li. 2020-09-29. Association of macular choroidal thickness with optical coherent tomography morphology in patients with idiopathic epiretinal membrane. PLOS ONE. 15. 9. e0239992. 10.1371/journal.pone.0239992. 1932-6203. 7523999. 32991629. 2020PLoSO..1539992F. free.
  29. Web site: Alon Harris. 2020-11-16. scholar.google.com. 2022-02-22. https://web.archive.org/web/20220222184353/https://scholar.google.com/citations?user=hZR_PzMAAAAJ&hl=en. live.
  30. Harris. A.. Sergott. R. C.. Spaeth. G. L.. Katz. J. L.. Shoemaker. J. A.. Martin. B. J.. 1994-11-01. Color Doppler Analysis of Ocular Vessel Blood Velocity in Normal-tension Glaucoma. American Journal of Ophthalmology. en. 118. 5. 642–649. 10.1016/S0002-9394(14)76579-1. 7977577. 0002-9394. 2021-04-05. 2022-02-22. https://web.archive.org/web/20220222184354/https://www.sciencedirect.com/science/article/abs/pii/S0002939414765791. live.
  31. Wu. Pengfei. Sato. Juichi. Zhao. Yu. Jaskiewicz. Jerzy. Popov. M. Kirill. Harris. A. Robert. 1998-01-01. Starvation and diabetes increase the amount of pyruvate dehydrogenase kinase isoenzyme 4 in rat heart. Biochemical Journal. en. 329. 1. 197–201. 10.1042/bj3290197. 9405294. 0264-6021. 1219032.
  32. Williamson. Tom H.. Harris. Alon. 1996-01-01. Color Doppler ultrasound imaging of theeye and orbit. Survey of Ophthalmology. en. 40. 4. 255–267. 10.1016/S0039-6257(96)82001-7. 8658337. 0039-6257. 2021-04-05. 2022-02-22. https://web.archive.org/web/20220222184411/https://www.sciencedirect.com/science/article/abs/pii/S0039625796820017. live.
  33. Hardarson. Sveinn Hakon. Harris. Alon. Karlsson. Robert Arnar. Halldorsson. Gisli Hreinn. Kagemann. Larry. Rechtman. Ehud. Zoega. Gunnar Már. Eysteinsson. Thor. Benediktsson. Jon Atli. Thorsteinsson. Adalbjorn. Jensen. Peter Koch. 2006-11-01. Automatic Retinal Oximetry. Investigative Ophthalmology & Visual Science. en. 47. 11. 5011–5016. 10.1167/iovs.06-0039. 17065521. 1552-5783. 2021-04-05. 2021-04-17. https://web.archive.org/web/20210417213819/https://iovs.arvojournals.org/article.aspx?articleid=2124798. live.
  34. Chung. Hak Sung. Harris. Alon. Kristinsson. Jóhannes Kári. Ciulla. Thomas A.. Kagemann. Carol. Ritch. Robert. 1999-06-01. Ginkgo biloba Extract Increases Ocular Blood Flow Velocity. Journal of Ocular Pharmacology and Therapeutics. 15. 3. 233–240. 10.1089/jop.1999.15.233. 10385132. 1080-7683. 2021-04-05. 2022-02-22. https://web.archive.org/web/20220222184419/https://www.liebertpub.com/doi/abs/10.1089/jop.1999.15.233. live.
  35. Chung. Hak Sung. Harris. Alon. Evans. David W.. Kagemann. Larry. Garzozi. Hanna J.. Martin. Bruce. 1999-06-01. Vascular Aspects in the Pathophysiology of Glaucomatous Optic Neuropathy. Survey of Ophthalmology. en. 43. S43–S50. 10.1016/S0039-6257(99)00050-8. 10416746. 0039-6257. 2021-04-05. 2022-02-22. https://web.archive.org/web/20220222184355/https://www.sciencedirect.com/science/article/abs/pii/S0039625799000508. live.
  36. Web site: Glaucoma: Harris, A - Expertscape.com . 2023-06-19 . expertscape.com.
  37. Web site: Alon Harris. 2020-11-29. World Glaucoma Congress 2021. en-US. 2022-02-22. https://web.archive.org/web/20220222184400/https://worldglaucomacongress.org/user/alon-harris/. live.
  38. Web site: Math modeling may provide greater understanding of glaucoma risk. 2020-11-29. Ophthalmology Times. 2020-10-24. https://web.archive.org/web/20201024210150/https://www.ophthalmologytimes.com/view/math-modeling-may-provide-greater-understanding-glaucoma-risk. live.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Alon Harris".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.